国家食药监总局:自7月起停止生产销售使用甲丙氨酯制剂

2013-05-27 晓静 整理 医学论坛网

  根据国家食品药品监督管理总局5月8日消息,国家食品药品监督管理总局发布了关于停止生产销售使用甲丙氨酯制剂的通知。通知指出,根据《药品管理法》第四十二条规定,国家食品药品监督管理总局决定自2013年7月1日起,停止甲丙氨酯制剂在我国的生产、销售和使用,撤销药品批准证明文件。   通知指出,经国家食品药品监督管理总局经再评价,认为甲丙氨酯制剂临床价值有限,发生严重不良反应的风险较高,长时间使用可

  根据国家食品药品监督管理总局5月8日消息,国家食品药品监督管理总局发布了关于停止生产销售使用甲丙氨酯制剂的通知。通知指出,根据《药品管理法》第四十二条规定,国家食品药品监督管理总局决定自2013年7月1日起,停止甲丙氨酯制剂在我国的生产、销售和使用,撤销药品批准证明文件。

  通知指出,经国家食品药品监督管理总局经再评价,认为甲丙氨酯制剂临床价值有限,发生严重不良反应的风险较高,长时间使用可能产生药物依赖,在我国使用风险大于效益。

  通知要求各省(区、市)食品药品监管部门立即将上述决定通知辖区内有关药品生产、经营、使用单位,并监督其遵照执行,已生产的甲丙氨酯制剂由当地食品药品监督管理部门监督销毁。

  撤销的甲丙氨酯制剂批准证明文件名单 

  序号

  通用名称

  批准文号

  生产单位

  1

  甲丙氨酯片

  国药准字H44020922

  广东众生药业股份有限公司

  2

  甲丙氨酯片

  国药准字H21024069

  朝阳富祥药业有限公司

  3

  甲丙氨酯片

  国药准字H50020361

  重庆科瑞制药(集团)有限公司

  4

  甲丙氨酯片

  国药准字H50020749

  重庆科瑞制药(集团)有限公司

  5

  甲丙氨酯片

  国药准字H41022329

  开封制药(集团)有限公司

  6

  甲丙氨酯片

  国药准字H41022328

  开封制药(集团)有限公司

  7

  甲丙氨酯片

  国药准字H13022769

  石药集团欧意药业有限公司

  8

  甲丙氨酯片

  国药准字H14021646

  山西远景康业制药有限公司

  9

  甲丙氨酯片

  国药准字H14021287

  大同星宇星火制药有限责任公司

  10

  甲丙氨酯片

  国药准字H41020986

  郑州永和制药有限公司

  11

  甲丙氨酯片

  国药准字H13021917

  河北东风药业有限公司

  12

  甲丙氨酯片

  国药准字H61022488

  西安利君制药有限责任公司

  13

  甲丙氨酯片

  国药准字H61022416

  西安利君制药有限责任公司

  14

  甲丙氨酯片

  国药准字H62020612

  甘肃新兰药药业有限公司

  15

  甲丙氨酯片

  国药准字H62020613

  甘肃新兰药药业有限公司

  16

  甲丙氨酯片

  国药准字H14021806

  山西云中制药有限责任公司

  17

  甲丙氨酯片

  国药准字H14020656

  大同长兴制药有限责任公司

  18

  甲丙氨酯片

  国药准字H61021423

  陕西永寿制药有限责任公司

  19

  甲丙氨酯片

  国药准字H61021422

  陕西永寿制药有限责任公司

  20

  甲丙氨酯片

  国药准字H52020396

  贵州光正制药有限责任公司

  21

  甲丙氨酯片

  国药准字H36020781

  江西制药有限责任公司

  22

  甲丙氨酯片

  国药准字H36020782

  江西制药有限责任公司

  23

  甲丙氨酯片

  国药准字H23022093

  黑龙江鼎恒升药业有限公司

  24

  甲丙氨酯片

  国药准字H42021694

  远大医药(中国)有限公司

  25

  甲丙氨酯片

  国药准字H23020081

  哈药集团三精制药四厂有限公司

  26

  甲丙氨酯片

  国药准字H23020080

  哈药集团三精制药四厂有限公司

  27

  甲丙氨酯片

  国药准字H33021435

  宁波大红鹰药业股份有限公司

  28

  甲丙氨酯片

  国药准字H21021527

  东北制药集团沈阳第一制药有限公司

  29

  甲丙氨酯片

  国药准字H21021526

  东北制药集团沈阳第一制药有限公司

  30

  甲丙氨酯片

  国药准字H32025324

  江苏吉贝尔药业有限公司

  31

  甲丙氨酯片

  国药准字H32025325

  江苏吉贝尔药业有限公司

  32

  甲丙氨酯片

  国药准字H46020446

  海南赛立克药业有限公司

  33

  甲丙氨酯片

  国药准字H11020967

  北京双鹤药业股份有限公司

  34

  甲丙氨酯片

  国药准字H11020966

  北京双鹤药业股份有限公司

  35

  甲丙氨酯片

  国药准字H62020166

  甘肃莫高实业发展股份有限公司制药厂

  36

  甲丙氨酯片

  国药准字H63020049

  青海制药厂有限公司

  37

  甲丙氨酯片

  国药准字H23022183

  牡丹江灵泰药业股份有限公司

  38

  甲丙氨酯片

  国药准字H37022531

  济南永宁制药股份有限公司

  39

  甲丙氨酯片

  国药准字H15020660

  赤峰蒙欣药业有限公司

  40

  甲丙氨酯片

  国药准字H15020201

  内蒙古兰太药业有限责任公司

  41

  甲丙氨酯片

  国药准字H43021035

  湖南湘药制药有限公司

  42

  甲丙氨酯片

  国药准字H43021076

  湖南湘药制药有限公司

  43

  甲丙氨酯片

  国药准字H14022418

  山西太原药业有限公司

  44

  甲丙氨酯片

  国药准字H50021195

  重庆西南制药二厂有限责任公司

  45

  甲丙氨酯片

  国药准字H20064715

  陕西西岳制药有限公司

  46

  甲丙氨酯片

  国药准字H20064716

  陕西西岳制药有限公司

  47

  甲丙氨酯片

  国药准字H22021877

  公主岭市红光制药厂

  48

  甲丙氨酯片

  国药准字H31020471

  上海华氏制药有限公司天平制药厂

  49

  甲丙氨酯片

  国药准字H15020213

  包头康力药业集团股份有限公司

  50

  甲丙氨酯片

  国药准字H15020214

  包头康力药业集团股份有限公司

  51

  甲丙氨酯片

  国药准字H44020365

  广州白云山光华制药股份有限公司

  52

  甲丙氨酯片

  国药准字H13022036

  保定康信药业有限公司

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1705849, encodeId=f9c81e058498d, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Mon Sep 09 22:15:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076181, encodeId=8ed020e6181ce, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Nov 30 11:15:00 CST 2013, time=2013-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840397, encodeId=fe96184039e9c, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Sat Aug 24 04:15:00 CST 2013, time=2013-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687247, encodeId=3755168e2476f, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Tue May 06 06:15:00 CST 2014, time=2014-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517679, encodeId=f52b151e67993, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Wed May 29 07:15:00 CST 2013, time=2013-05-29, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1705849, encodeId=f9c81e058498d, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Mon Sep 09 22:15:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076181, encodeId=8ed020e6181ce, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Nov 30 11:15:00 CST 2013, time=2013-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840397, encodeId=fe96184039e9c, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Sat Aug 24 04:15:00 CST 2013, time=2013-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687247, encodeId=3755168e2476f, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Tue May 06 06:15:00 CST 2014, time=2014-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517679, encodeId=f52b151e67993, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Wed May 29 07:15:00 CST 2013, time=2013-05-29, status=1, ipAttribution=)]
    2013-11-30 cmsvly
  3. [GetPortalCommentsPageByObjectIdResponse(id=1705849, encodeId=f9c81e058498d, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Mon Sep 09 22:15:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076181, encodeId=8ed020e6181ce, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Nov 30 11:15:00 CST 2013, time=2013-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840397, encodeId=fe96184039e9c, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Sat Aug 24 04:15:00 CST 2013, time=2013-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687247, encodeId=3755168e2476f, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Tue May 06 06:15:00 CST 2014, time=2014-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517679, encodeId=f52b151e67993, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Wed May 29 07:15:00 CST 2013, time=2013-05-29, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1705849, encodeId=f9c81e058498d, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Mon Sep 09 22:15:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076181, encodeId=8ed020e6181ce, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Nov 30 11:15:00 CST 2013, time=2013-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840397, encodeId=fe96184039e9c, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Sat Aug 24 04:15:00 CST 2013, time=2013-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687247, encodeId=3755168e2476f, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Tue May 06 06:15:00 CST 2014, time=2014-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517679, encodeId=f52b151e67993, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Wed May 29 07:15:00 CST 2013, time=2013-05-29, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1705849, encodeId=f9c81e058498d, content=<a href='/topic/show?id=76e510114468' target=_blank style='color:#2F92EE;'>#食药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101144, encryptionId=76e510114468, topicName=食药监总局)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a73b31099952, createdName=lilili1114, createdTime=Mon Sep 09 22:15:00 CST 2013, time=2013-09-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2076181, encodeId=8ed020e6181ce, content=<a href='/topic/show?id=b4351011422b' target=_blank style='color:#2F92EE;'>#食药监#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101142, encryptionId=b4351011422b, topicName=食药监)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=aad0444, createdName=cmsvly, createdTime=Sat Nov 30 11:15:00 CST 2013, time=2013-11-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1840397, encodeId=fe96184039e9c, content=<a href='/topic/show?id=186b8e937c6' target=_blank style='color:#2F92EE;'>#药监总局#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=87937, encryptionId=186b8e937c6, topicName=药监总局)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=19ad38, createdName=lq1767, createdTime=Sat Aug 24 04:15:00 CST 2013, time=2013-08-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1687247, encodeId=3755168e2476f, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96665, encryptionId=df72966659b, topicName=销售)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0bca28361924, createdName=1249862am81(暂无昵称), createdTime=Tue May 06 06:15:00 CST 2014, time=2014-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1517679, encodeId=f52b151e67993, content=<a href='/topic/show?id=44156886664' target=_blank style='color:#2F92EE;'>#生产#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68866, encryptionId=44156886664, topicName=生产)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=37a111112788, createdName=ms1343860338762272, createdTime=Wed May 29 07:15:00 CST 2013, time=2013-05-29, status=1, ipAttribution=)]